Frontier IP announces that its portfolio company Cambridge Raman Imaging Ltd (“CRI” or the “Company“) has put in place a loan facility with Frontier IP of up to £0.6 million (the “Loan Facility“) to fund CRI’s short-term working capital requirements during a period of accelerated growth. Upon completion of the Loan Facility, CRI has drawn […]
Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced today the completion of a $20M financing from new and existing investors. The funding is expected to enable the Company to drive an expansion of the successful Orion Spatial Biology […]
GRAIL spin-off complete; GRAIL to begin regular way trading as “GRAL” on June 25 Illumina to issue second quarter 2024 results on August 6; leadership to present Strategy Update on August 13 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the successful completion of the spin-off of GRAIL. This milestone follows the company’s previously announced […]
Hosts Capital Markets Day event in New York to outline strategy anchored by sharpened focus on growth pillars set to drive about 7% CER sales CAGR from 2024-2028 Targeting at least 31% CER adjusted operating income margin in 2028 from portfolio streamlining (including NeuMoDx decision), operational efficiency gains and digitization Ensuring disciplined capital allocation with […]
“When-issued” trading expected to begin on or about June 12, 2024 Record date for distribution of GRAIL shares will be June 13, 2024 Distribution date for GRAIL shares anticipated to be June 24, 2024 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is […]
Limula founders: Luc Henry, CEO, Yann Pierson, CTO and Thomas Eaton, COO. Photograph CC-BY Jonathan Moy de Vitry RHRN.ch Limula leverages ‘Swiss Made’ engineering and an experienced team to brings much-needed innovation to the field of Cell and Gene Therapy. Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time, […]
· Led by Voima Ventures and co-led by existing investor Eir Ventures · Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to late formulation Stockholm, Sweden: ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising […]
SAN CARLOS, Calif. — Cache DNA, Inc., a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round. The team raised an undisclosed amount from notable investors, including Climate Capital Bio, Exor Ventures, Hawktail, LifeX Ventures, Pillar VC, and Trousdale Ventures, including support from Illumina and founders […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results Preliminary revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. Instrument revenue of $19.0 million compared with $20.7 million in the prior-year […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
